Clinicopathological features and prognostic factors of primary pulmonary adenoid cystic carcinoma: a study of 59 cases
10.3760/cma.j.issn.0529-5807.2019.03.007
- VernacularTitle: 原发肺腺样囊性癌59例临床病理学特征及预后因素分析
- Author:
Jing HAN
1
;
Xianzheng GAO
1
;
Jianguo WEI
2
;
Yilin XIE
1
;
Yaqing LIU
1
;
Wencai LI
1
;
Shenglei LI
1
Author Information
1. Department of Pathology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China
2. Department of Pathology, Shaoxing People′s Hospital, Zhejiang Province, Shaoxing 312000, China
- Publication Type:Journal Article
- Keywords:
Lung neoplasms;
Carcinoma, adenoid cystic;
Pathology, surgical;
Prognosis
- From:
Chinese Journal of Pathology
2019;48(3):204-208
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinicopathological features and prognostic indicators of primary pulmonary adenoid cystic carcinoma.
Methods:Fifty-nine cases of primary pulmonary adenoid cystic carcinoma were collected from August 2011 to December 2017 at the First Affiliated Hospital of Zhengzhou University. All cases were retrospectively studied by hematoxylin-eosin staining and immunohistochemistry. The clinicopathological features were reviewed and patient survival analysis was performed using Kaplan-Meier method and Cox regression model. Status of epidermal growth factor receptor (EGFR), KRAS, BRAF genes was analyzed in 15 of the 59 study cases.
Results:Among 59 cases, there were 25 males and 34 females with male to female ratio of 1.0 to 1.4. The patient age ranged from 29 to 81 years with a mean age of 55 years. The tumor max diameters ranged from 1.0 to 9.6 cm with an average diameter of 2.8 cm. Fifteen (25.4%) patients were smokers while 44 patients (74.6%) were non-smokers. Tumors predominantly occurred in the trachea (28/59,47.5%), the left main bronchus (7/59,11.9%) and the right bronchus (5/59,8.5%). Grossly, the tumors were well circumscribed, greyish-white nodules. Microscopically the tumor cells were small and uniform, and arranged in tubular, cribriform, and solid patterns. Immunohistochemistry showed that the tumor cells were positive for CK7, S-100 protein, Sox-10, CD117 and p63. TTF1 was only positive in 2 cases and Ki-67 index ranged from 3% to 40%. Eighteen cases (30.5%) were gradeⅠ, 26 cases (40.1%) grade Ⅱ, and 15 cases (25.4%) grade Ⅲ. Overall, 39 cases (66.1%), 7 cases (11.9%), 10 cases (16.9%), and 3 cases (5.1%) were at stages Ⅰ, Ⅱ, Ⅲ, and Ⅳ, respectively. Twenty-three patients (39.0%) received surgical therapy, 3 patients (5.1%) surgery combined with radiotherapy, 9 patients (15.2%) surgery combined with chemotherapy, and 24 cases (40.7%) chemotherapy only. No mutation of EGFR, KRAS and BRAF was detected in all 15 tested cases. The overall survival rate at the first, third and fifth years was 94.9%, 86.4% and 84.7%, respectively. Prognostic analysis showed that patient′s age and tumor size were statistically associated with the survival (P<0.05).
Conclusions:Majority of the patients with primary pulmonary adenoid cystic carcinoma are at an early clinical stage with a favorable prognosis. The size of the tumor and the age of the patients are independent prognostic indicators.
